Development of an algorithm for the identification of leukemic hematolymphoid neoplasms in Primary Care patients

References

1. Barnes PW, McFadden SL, Machin SJ, Simson E, international consensus group for hematology. The international consensus group for hematology review: suggested criteria for action following automated CBC and WBC differential analysis. Lab Hematol 2005;11:83–90.10.1532/LH96.05019Suche in Google Scholar PubMed

2. Bain BJ. Diagnosis from the blood smear. N Engl J Med 2005;353:498–507.10.1056/NEJMra043442Suche in Google Scholar PubMed

3. Abel GA, Friese CR, Neville BA, Wilson KM, Hastings BT, Earle CC, et al. Referrals for suspected hematologic malignancy: a survey of primary care physicians. PMC 2013;87:634–6.10.1002/ajh.23172Suche in Google Scholar PubMed PubMed Central

4. Sun P, Kowalski EM, Cheng CK, Shawwa A, Liwski RS, Juskevicius R. Predictive significance of absolute lymphocyte count and morphology in adults with a new onset peripheral blood lymphocytosis. J Clin Pathol 2014;67:1062–6.10.1136/jclinpath-2014-202545Suche in Google Scholar PubMed

5. Tseng V, Morgan AS, Leith CP, Yang DT. Efficient assessment of peripheral blood lymphocytosis in adults : developing new thresholds for blood smear review by pathologists. Clin Chem Lab Med 2014;52:1763–70.10.1515/cclm-2014-0320Suche in Google Scholar PubMed

6. Abel GA, Friese CR, Magazu LS, Richardson LC, Fernandez ME, De Zengotita JJ, et al. Delays in referral and diagnosis for chronic hematologic malignancies: a literature review. Leuk Lymphoma 2008;49:1352–9.10.1080/10428190802124281Suche in Google Scholar PubMed

7. Béné MC, Grimwade D, Haferlach C, Haferlach T, Zini G. Leukemia diagnosis: today and tomorrow. Eur J Haematol 2015;95:365–73.10.1111/ejh.12603Suche in Google Scholar PubMed

8. van Dongen JJ, Orfao A. EuroFlow: resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine. Leukemia 2012;26:1899–907.10.1038/leu.2012.121Suche in Google Scholar PubMed PubMed Central

9. van Dongen JJ, Lhermitte L, Bo S, Kalina T, Tute R De, Bru M, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012;26:1908–75.10.1038/leu.2012.120Suche in Google Scholar PubMed PubMed Central

10. Béné MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, et al. Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia 2011;25:567–74.10.1038/leu.2010.312Suche in Google Scholar PubMed

11. Selimoglu-Buet D, Wagner-Ballon O, Saada V, Bardet V, Itzykson R, Bencheikh L, et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood 2015;125:3618–26.10.1182/blood-2015-01-620781Suche in Google Scholar PubMed PubMed Central

12. Kroft SH, Harrington AM. Flow cytometry of B-cell neoplasms. Clin Lab Med 2017;37:697–723.10.1016/j.cll.2017.07.001Suche in Google Scholar PubMed

13. Criado I, Rodríguez-Caballero A, Gutiérrez ML, Pedreira CE, Alcoceba M, Nieto W, et al. Low-count monoclonal B-cell lymphocytosis persists after 7 years of follow-up and is associated with a poorer outcome. Haematologica 2018;103:1198–208.10.3324/haematol.2017.183954Suche in Google Scholar PubMed PubMed Central

14. Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Schwager S, et al. Survival of patients with clinically identified monoclonal B-cell lymphocytosis (MBL) relative to the age- and sex-matched general population. Leukemia 2012;26:373–6.10.1038/leu.2011.211Suche in Google Scholar PubMed

15. Strati P, Shanafelt TD. Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification. Blood 2015;126:454–62.10.1182/blood-2015-02-585059Suche in Google Scholar PubMed PubMed Central

16. Davis BH, Holden JT, Bene MC, Borowitz MJ, Braylan RC, Cornfield D, et al. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications. Cytom Part B Clin Cytom 2007;72B(S1):S5–13.10.1002/cyto.b.20365Suche in Google Scholar PubMed

17. Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ, et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry B Clin Cytom 2007;72(S1):S14–22.10.1002/cyto.b.20363Suche in Google Scholar PubMed

18. Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP, et al. Initial diagnostic workup of acute leukemia: guideline from the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med 2017;arpa.2016-0504-CP.10.5858/arpa.2016-0504-CPSuche in Google Scholar PubMed

19. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H, et al. Guidelines for diagnosis, indications for treatment, response assessment and supportive management of chronic lymphocytic leukemia. Blood 2018;131:2745–60.10.1182/blood-2017-09-806398Suche in Google Scholar PubMed

20. Kalina T, Flores-Montero J, van der Velden VH, Martin-Ayuso M, Böttcher S, Ritgen M, et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 2012;26:1986–2010.10.1038/leu.2012.122Suche in Google Scholar PubMed PubMed Central

21. van der Velden VH, Flores-Montero J, Perez M, Martin-Ayuso M, Crespo O, Blanco E, et al. Optimization and testing of dried antibody tube: the EuroFlow LST and PIDOT tubes as examples. J Immunol Methods 2017;S0022-1759:30095-9.Suche in Google Scholar

22. Engel-Nitz NM, Eckert B, Song R, Koka P, Hulbert EM, McPheeters J, et al. Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes. BMC Clin Pathol 2014;14:17.10.1186/1472-6890-14-17Suche in Google Scholar PubMed PubMed Central

23. Shanafelt TD, Rabe KG, Kay NE, Zent CS, Jelinek DF, Reinalda MS, et al. Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia. Cancer 2010;116:4777–87.10.1002/cncr.25292Suche in Google Scholar PubMed PubMed Central

24. Howell DA, Macleod U, Roman E, Patmore R, Smith AG, Hart RI. Disease-related factors affecting timely lymphoma diagnosis: a qualitative study exploring patient experiences. Br J Gen Pract 2019;69:e134–45.10.3399/bjgp19X701009Suche in Google Scholar PubMed PubMed Central

25. Johnston A, McFarlane A, Bourner G, Martin T, Padmore R. Distinguishing morphology of reactive versus abnormal neoplastic peripheral blood lymphocytosis. Challenges illustrated by two proficiency testing surveys. Int J Lab Hematol 2016;38:e41–4.10.1111/ijlh.12469Suche in Google Scholar PubMed

26. Bosch X, Sanclemente-Ansó C, Escoda O, Monclús E, Franco-Vanegas J, Moreno P, et al. Time to diagnosis and associated costs of an outpatient vs inpatient setting in the diagnosis of lymphoma: a retrospective study of a large cohort of major lymphoma subtypes in Spain. BMC Cancer 2018;18:1–15.10.1186/s12885-018-4187-ySuche in Google Scholar PubMed PubMed Central

27. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008;111:3941–67.10.1182/blood-2007-11-120535Suche in Google Scholar PubMed

28. Béné MC, Le Bris Y, Robillard N, Wuillème S, Fouassier M, Eveillard M. Flow cytometry in hematological nonmalignant disorders. Int J Lab Hematol 2016;38:5–16.10.1111/ijlh.12438Suche in Google Scholar PubMed

29. Andrews J, Cruser D, Myers J, Fernelius C, Holm M, Waldner D. Using peripheral smear review, age and absolute lymphocyte count as predictors of abnormal peripheral blood lymphocytoses diagnosed by flow cytometry. Leuk Lymphoma 2008;49:1731–7.10.1080/10428190802251787Suche in Google Scholar PubMed

30. van der Meer W, van Gelder W, de Keijzer R, Willems H. The divergent morphological classification of variant lymphocytes in blood smears. J Clin Pathol 2007; 60:838–9.10.1136/jcp.2005.033787Suche in Google Scholar PubMed PubMed Central

31. Richards SJ, Jack AS. The development of integrated haematopathology laboratories: a new approach to the diagnosis of leukaemia and lymphoma. Clin Lab Haematol 2003;25:337–42.10.1046/j.0141-9854.2003.00559.xSuche in Google Scholar PubMed

32. Leith CP. Cost-effective flow cytometry testing strategies. Clin Lab Med 2017;37:915–29.10.1016/j.cll.2017.07.012Suche in Google Scholar PubMed

33. Craig FE. The utility of peripheral blood smear review for identifying specimens for flow cytometric immunophenotyping. Int J Lab Hematol 2017;39:41–6.10.1111/ijlh.12651Suche in Google Scholar PubMed

34. Rawstron AC, Bennett FL, O’Connor SJ, Kwok M, Fenton JA, Plummer M, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008;359:575–83.10.1056/NEJMoa075290Suche in Google Scholar PubMed

35. Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF, et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009;114:33–7.10.1182/blood-2009-01-197368Suche in Google Scholar PubMed

36. Parikh SA, Rabe KG, Kay NE, Call TG, Ding W, Schwager SM, et al. Chronic lymphocytic leukemia in young (≤ 55 years) patients: a comprehensive analysis of prognostic factors and outcomes. Haematologica 2014;99:140–7.10.3324/haematol.2013.086066Suche in Google Scholar PubMed PubMed Central

37. Cao F, Wang S, Zhao H, Zhou J, Yang G, Wang C. T-cell clonality is detected in a high frequency among patients with incidental lymphocytosis by PCR assays for TCR gene rearrangements. J Clin Pathol 2013;66:749–52.10.1136/jclinpath-2012-201417Suche in Google Scholar PubMed

38. Cao F, Zhao H, Li Y, Dai S, Wang C. Clinicopathological and phenotypic features of chronic NK cell lymphocytosis identified among patients with asymptomatic lymphocytosis. Int J Lab Hematol 2015;37:783–90.10.1111/ijlh.12410Suche in Google Scholar PubMed

39. Sanchez ML, Almeida J, Lopez A, Sayagues JM, Rasillo A, Sarasquete EA, et al. Heterogeneity of neoplastic cells in B-cell chronic lymphoproliferative disorders: biclonality versus intraclonal evolution of a single tumor cell clone. Haematologica 2006;91:331–9.Suche in Google Scholar

40. Sanchez ML, Almeida J, Gonzalez D, Gonzalez M, Garcia-Marcos MA, Balanzategui A, et al. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood 2003;102:2994–3002.10.1182/blood-2003-01-0045Suche in Google Scholar PubMed

41. Henriques A, Rodríguez-Caballero A, Criado I, Langerak AW, Nieto WG, Lécrevisse Q, et al. Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders. Haematologica 2014;99:897–907.10.3324/haematol.2013.098913Suche in Google Scholar PubMed PubMed Central